Description

Quanil (citicoline sodium) Coated Tablets 500 mg. №30

Ingredients

Active ingredient: Each coated tablet contains 500 mg of citicoline sodium.

Dosage

Recommended dosage: Take one tablet orally, twice daily, or as directed by a healthcare professional.

Indications

Quanil (citicoline sodium) tablets are indicated for the treatment of cognitive impairments in various conditions such as stroke, dementia, and head trauma.

Contraindications

Do not use Quanil tablets if you are allergic to citicoline sodium or any other ingredients in the product. Consult a healthcare provider before use if you are pregnant, nursing, or have any medical conditions.

Directions

Swallow the tablets whole with water. Do not crush or chew the tablets. It is recommended to take Quanil tablets with food to enhance absorption.

Scientific Evidence

Citicoline, the active ingredient in Quanil tablets, has been extensively studied for its neuroprotective and cognitive-enhancing properties. Research has shown that citicoline supplementation can improve cognitive function, memory, and overall brain health.

Additional Information

Quanil tablets have been formulated using advanced technology to ensure maximum efficacy and bioavailability of citicoline sodium. These coated tablets provide a convenient and easy way to support brain function and cognitive health.

Pharmacological Effects: Citicoline functions as an intermediate in the synthesis of phosphatidylcholine, a key component of brain cell membranes. By increasing phosphatidylcholine levels, citicoline promotes neuronal membrane repair and enhances neurotransmitter production, leading to improved cognitive function.

Clinical Trials: Clinical trials have demonstrated the effectiveness of citicoline in improving cognitive function and reducing cognitive decline in patients with various neurological disorders. A study published in the Journal of Neural Transmission showed that citicoline supplementation significantly improved memory and attention in patients with mild cognitive impairment.